TOXINEERING. “The researchers identified a tarantula spider peptide, protoxin-I, as the first high-affinity peptide antagonist of the transient receptor potential ankyrin 1 (TRPA1) channel. Nitabach’s team also used toxineering to create a novel protoxin-I mutant with improved specificity for TRPA1, underscoring the value of the approach for pharmaceutical discovery.”
https://lnkd.in/eQA7Yck
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022